Ligand validation:8R9L

HEM: PROTOPORPHYRIN IX CONTAINING FE

HEM is a Ligand Of Interest in 8R9L designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8R9L_HEM_A_201	93%	34%	0.087	0.982	1.44	1.17	3	2	0	0	100%	0.52
3VM9_HEM_A_154	99%	32%	0.058	0.993	1.23	1.46	3	7	0	0	100%	1
2FRJ_HEM_X_154	98%	16%	0.061	0.987	1.77	1.88	7	10	0	0	100%	1
2V1F_HEM_A_1154	98%	21%	0.066	0.989	1.78	1.55	4	4	0	0	100%	0.9535
8R8W_HEM_A_201	98%	31%	0.067	0.989	1.44	1.32	3	6	0	0	100%	0.64
8R8X_HEM_A_201	98%	31%	0.067	0.989	1.44	1.32	3	6	0	0	100%	0.64
5YCE_HEM_A_201	100%	37%	0.036	0.997	1.14	1.34	2	6	1	0	100%	1
1GWE_HEM_A_504	100%	43%	0.041	0.998	0.98	1.21	1	6	0	0	100%	1
3X34_HEM_A_101	100%	28%	0.043	0.997	1.33	1.54	8	12	2	0	100%	0.8972
8IAG_HEM_B_301	100%	23%	0.04	0.992	1.7	1.5	4	5	0	0	100%	1
1BZ6_HEM_A_154	100%	39%	0.044	0.995	1.19	1.21	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.